SequelSEC

CARDINAL HEALTH INC CAH

Wholesale-Drugs, Proprietaries & Druggists' Sundries · CIK 0000721371 · Fiscal year ends 0630

Revenue
$254.25B
Fiscal year ended 2026-06-30
Operating income
$2.61B
Fiscal year ended 2026-06-30
Free cash flow
$4.52B
Fiscal year ended 2026-06-30

CARDINAL HEALTH INC (CAH) reported revenue of $254.25B and net income of $1.71B for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from CARDINAL HEALTH INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Wholesale-Drugs, Proprietaries & Druggists' Sundries.

Income

CARDINAL HEALTH INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
Revenue$254.25B$222.58B$226.83B$204.98B$181.33B$162.47B$152.92B$145.53B$136.81B$129.98B
Cost of revenue$244.47B$214.41B$219.41B$198.10B$174.84B$155.69B$146.05B$138.70B$129.63B$123.43B
Gross profit$9.77B$8.17B$7.41B$6.87B$6.48B$6.78B$6.87B$6.83B$7.18B$6.54B
Operating income$2.61B$2.28B$1.24B$752.00M-$607.00M$472.00M-$4.10B$2.06B$126.00M$2.12B
Net income$1.71B$1.56B$852.00M$330.00M-$938.00M$611.00M-$3.70B$1.36B$256.00M$1.29B
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 237.00Mshares 242.00Mshares 247.00Mshares 262.00Mshares 279.00Mshares 294.00Mshares 293.00Mshares 301.00Mshares 315.00Mshares 320.00M
Pretax income$2.17B$2.10B$1.20B$663.00M-$784.00M$323.00M-$3.77B$1.75B-$228.00M$1.92B
Income tax expense$469.00M$532.00M$348.00M$332.00M$153.00M-$289.00M-$79.00M$386.00M-$487.00M$630.00M
Diluted EPS$7.23$6.45$3.45$1.26$-3.37$2.08$-12.61$4.53$0.81$4.03
Selling, general & administrative$6.13B$5.38B$5.00B$4.80B$4.51B$4.53B$4.57B$4.48B$4.60B$3.78B
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

CARDINAL HEALTH INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
Cash & equivalents$4.86B$3.87B$5.13B$4.08B$4.72B$3.41B$2.77B$2.53B$1.76B$6.88B
Total assets$57.30B$53.12B$45.12B$43.35B$43.88B$44.45B$40.77B$40.96B$39.95B$40.11B
Current assets$38.75B$36.37B$34.88B$33.74B$32.94B$31.05B$25.94B$25.75B$24.55B$28.34B
Total liabilitiesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current liabilities$43.90B$38.90B$35.64B$33.74B$30.55B$27.62B$23.62B$24.11B$22.89B$21.22B
Total equity incl. NCI-$2.72B-$2.63B-$3.21B-$2.96B-$882.00M$1.62B$1.79B$6.33B$6.06B$6.83B
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$0$12.00M$118.00M
Inventory$17.30B$16.83B$14.96B$16.12B$15.64B$14.59B$13.20B$12.82B$12.31B$11.30B
Accounts receivable$13.82B$13.24B$12.08B$11.11B$10.56B$9.10B$8.26B$8.45B$7.80B$8.05B
Goodwill$11.44B$9.69B$4.72B$4.61B$5.86B$7.99B$8.36B$8.38B$8.32B$7.22B
Long-term debt$7.00B$7.98B$4.66B$3.91B$4.74B$5.36B$6.76B$7.58B$8.01B$9.07B
Accounts payable$38.28B$34.71B$31.76B$29.93B$27.13B$23.70B$21.37B$21.54B$19.68B$17.91B

Cash flow

CARDINAL HEALTH INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
Operating cash flow$5.17B$2.40B$3.76B$2.84B$3.18B$2.43B$1.96B$2.72B$2.77B$1.18B
Capital expenditures$649.00M$547.00M$511.00M$481.00M$387.00M$400.00M$375.00M$328.00M$384.00M$387.00M
Investing cash flow-$2.58B-$5.59B-$1.85B-$454.00M$567.00M-$378.00M$493.00M$338.00M-$5.61B-$405.00M
Financing cash flow-$1.60B$1.94B-$847.00M-$3.05B-$2.46B-$1.32B-$2.20B-$2.29B-$2.28B$3.75B
Net change in cash$982.00M-$1.26B$1.06B-$669.00M$1.36B$636.00M$240.00M$768.00M-$5.12B$4.52B
Stock-based compensation$367.00M$244.00M$121.00M$96.00M$81.00M$89.00M$90.00M$82.00M$85.00M$96.00M
Common dividends paid$491.00M$494.00M$499.00M$525.00M$559.00M$573.00M$569.00M$577.00M$581.00M$577.00M
Common share repurchases$1.36B$765.00M$750.00M$2.00B$1.00B$200.00M$350.00M$600.00M$550.00M$600.00M
Depreciation & amortization$956.00M$790.00M$710.00M$692.00M$692.00M$783.00M$913.00M$1.00B$1.03B$717.00M

Derived

CARDINAL HEALTH INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
Free cash flow$4.52B$1.85B$3.25B$2.36B$2.79B$2.03B$1.58B$2.39B$2.38B$797.00M
Gross margin3.8%3.7%3.3%3.4%3.6%4.2%4.5%4.7%5.2%5.0%
Operating margin1.0%1.0%0.5%0.4%-0.3%0.3%-2.7%1.4%0.1%1.6%
FCF margin1.8%0.8%1.4%1.2%1.5%1.2%1.0%1.6%1.7%0.6%
SBC / revenue0.1%0.1%0.1%0.0%0.0%0.1%0.1%0.1%0.1%0.1%
Current ratio0.88x0.94x0.98x1.00x1.08x1.12x1.10x1.07x1.07x1.34x
Revenue YoY growth14.2%-1.9%10.7%13.0%11.6%6.2%5.1%6.4%5.3%Unavailable
Net margin0.7%0.7%0.4%0.2%-0.5%0.4%-2.4%0.9%0.2%1.0%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenue0.3%0.2%0.2%0.2%0.2%0.2%0.2%0.2%0.3%0.3%
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rate21.6%25.3%29.0%50.1%Unavailable-89.5%Unavailable22.0%Unavailable32.7%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CAH in the interactive workspace to inspect any figure back to its filing.

Source filings

10-K · Filed 2026-08-11View SEC filing
10-Q · Filed 2026-02-05View SEC filing
10-Q · Filed 2025-10-30View SEC filing
10-K · Filed 2025-08-12View SEC filing
10-Q · Filed 2025-05-01View SEC filing
10-Q · Filed 2025-01-30View SEC filing

Companies in the same industry

Reconciliation checks needing review

2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

cash flow reconciliationreview2022-06-30

Operating, investing and financing flows differ from the reported change in cash by 109000000, beyond tolerance 31750000.00.

cash flow reconciliationreview2021-06-30

Operating, investing and financing flows differ from the reported change in cash by 109000000, beyond tolerance 24290000.00.